SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-031664
Filing Date
2018-05-09
Accepted
2018-05-09 14:31:03
Documents
47
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-8666_110q.htm 10-Q 774656
2 EX-31.1 a18-8666_1ex31d1.htm EX-31.1 9685
3 EX-31.2 a18-8666_1ex31d2.htm EX-31.2 9679
4 EX-32.1 a18-8666_1ex32d1.htm EX-32.1 8283
  Complete submission text file 0001104659-18-031664.txt   4835066

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT fold-20180331.xml EX-101.INS 1141303
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20180331.xsd EX-101.SCH 30636
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20180331_cal.xml EX-101.CAL 60454
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20180331_def.xml EX-101.DEF 148821
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT fold-20180331_lab.xml EX-101.LAB 412644
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20180331_pre.xml EX-101.PRE 276770
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 18817771
SIC: 2834 Pharmaceutical Preparations